Taking three blood thinner medications at once can be a necessary treatment for some patients, but including Xarelto in that mix can cause the risk of severe bleeding to skyrocket, attorneys suing two major drug companies on behalf of a man who suffered a near fatal bleed told a Philadelphia jury Friday.

The arguments came during opening statements in Russell v. Janssen Pharmaceuticals, which is the second Xarelto case to be tried in Philadelphia state court. The case focuses on plaintiff Daniel Russell, who suffered a bleed in 2011 while he was taking Xarelto along with Aspirin and Plavix, which is often called dual antiplatelet therapy.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]